Allosteric modulation and accelerated resensitization of human P2X(3) receptors by cibacron blue.

The activity of ATP as a fast neurotransmitter is mediated by the P2X family of ligand-gated ion channels. P2X receptor subtypes are subject to functional modulation by a diverse set of factors, including pH, divalent cations, and temperature. The human P2X(3) (hP2X(3)) receptor subunit is expressed primarily in sensory ganglia where it exists as either a homomultimeric receptor or, in combination with P2X(2), as a heteromultimeric receptor. This article describes the allosteric modulatory effect of the putative P2X receptor antagonist cibacron blue on the activity of recombinant hP2X(3) receptors. In 1321N1 cells expressing the hP2X(3) receptor, cibacron blue mediated a 3- to 7-fold increase in both the magnitude and the potency of ATP-activated Ca(2+) influx and transmembrane currents. The half-maximal concentration of cibacron blue required to mediate maximal potentiation (EC(50) = 1.4 microM) was independent of the agonist used to activate the hP2X(3) receptor. The nonselective P2 receptor antagonist PPADS (pyridoxal-5-phosphate-6-azophenyl-2',4'-disulfonic acid) caused a rightward shift of the cibacron blue concentration-effect curve, whereas increasing concentrations of cibacron blue attenuated PPADS antagonism. In addition to potentiating the effects of ATP at the hP2X(3) receptor, cibacron blue also produced a 6-fold increase in the rate of hP2X(3) receptor recovery from desensitization (from T(1/2) = 15.9 to 2.6 min), as evidenced by its ability to restore ATP responsiveness to acutely desensitized receptors. Consistent with the properties of other ligand-gated ion channels, these results suggest that hP2X(3) receptor activity can be allosterically modulated by a ligand distinct from the endogenous agonist.

[1]  W. Stühmer,et al.  Molecular characterization and pharmacological properties of the human P2X3 purinoceptor. , 1997, Brain research. Molecular brain research.

[2]  B. Talamo,et al.  Coomassie Brilliant Blue G is a more potent antagonist of P2 purinergic responses than Reactive Blue 2 (Cibacron Blue 3GA) in rat parotid acinar cells. , 1989, Biochemical and biophysical research communications.

[3]  F. F. Weight,et al.  Proton potentiation of ATP-gated ion channel responses to ATP and Zn2+ in rat nodose ganglion neurons. , 1996, Journal of neurophysiology.

[4]  E. Mccleskey,et al.  A Memory for Extracellular Ca2+ by Speeding Recovery of P2X Receptors from Desensitization , 1998, The Journal of Neuroscience.

[5]  W. Rice,et al.  Reactive blue 2 selectively inhibits P2y‐purinoceptor‐stimulated surfactant phospholipid secretion from rat isolated alveolar Type II cells , 1989, British journal of pharmacology.

[6]  E. Sigel,et al.  The benzodiazepine binding site of GABAA receptors. , 1997, Trends in pharmacological sciences.

[7]  T. Egan,et al.  Co-expression of P2X1 and P2X5 receptor subunits reveals a novel ATP-gated ion channel. , 1998, Molecular pharmacology.

[8]  E A Kowaluk,et al.  P2X receptor-mediated ionic currents in dorsal root ganglion neurons. , 1999, Journal of neurophysiology.

[9]  S. Kokubun,et al.  Contribution of P2‐purinoceptors to neurogenic contraction of rat urinary bladder smooth muscle , 1995, British journal of pharmacology.

[10]  A. Surprenant,et al.  Functional properties of native and cloned P2X receptors. , 1996, Ciba Foundation symposium.

[11]  A. Nicke,et al.  P2X1 and P2X3 receptors form stable trimers: a novel structural motif of ligand‐gated ion channels , 1998, The EMBO journal.

[12]  J. Stout,et al.  Inhibition of purified chicken gizzard smooth muscle ecto-ATPAse by P2 purinoceptor antagonists. , 1995, Biochemistry and molecular biology international.

[13]  K. J. Miller,et al.  Cibacron blue allosterically modulates the rat P2X4 receptor , 1998, Neuropharmacology.

[14]  R. North,et al.  Coexpression of P2X2 and P2X3 receptor subunits can account for ATP-gated currents in sensory neurons , 1995, Nature.

[15]  G. Burnstock,et al.  Effects of P2-purinoceptor antagonists on degradation of adenine nucleotides by ecto-nucleotidases in folliculated oocytes of Xenopus laevis. , 1996, Biochemical pharmacology.

[16]  F. F. Weight,et al.  Acid pH augments excitatory action of ATP on a dissociated mammalian sensory neuron , 1996, Neuroreport.

[17]  T. van Biesen,et al.  Pharmacological characterization of recombinant human and rat P2X receptor subtypes. , 1999, European journal of pharmacology.

[18]  P. Randall,et al.  A partial agonist model used in the allosteric modulation of the NMDA receptor. , 1997, European journal of pharmacology.

[19]  Frederick Sachs,et al.  Single Channel Properties of P2X2 Purinoceptors , 1999, The Journal of general physiology.

[20]  S. Choe,et al.  Molecular assembly of the extracellular domain of P2X2, an ATP-gated ion channel. , 1997, Biochemical and biophysical research communications.

[21]  G Burnstock,et al.  Receptors for purines and pyrimidines. , 1998, Pharmacological reviews.

[22]  G. Burnstock,et al.  An electrophysiological analysis of the effect of reactive blue 2, a putative P2-purinoceptor antagonist, on inhibitory junction potentials of rat caecum. , 1986, European journal of pharmacology.

[23]  P. Séguéla,et al.  Central P2X4 and P2X6 Channel Subunits Coassemble into a Novel Heteromeric ATP Receptor , 1998, The Journal of Neuroscience.

[24]  R. North,et al.  Different sensitivities to pH of ATP-induced currents at four cloned P2X receptors. , 1997, Journal of neurophysiology.